세부 프로그램

4/14(목) Day1

시간 Session A 연자/좌장
12:40-13:55 Multidimensional Immune Cell Analysis 박윤 (KIST)
김태균 (연세대)
12:40-13:10 From Terminology to Insight Shirly Phoon
(Beckman Coulter Lifescience)
13:10-13:35 Spatial multi-omics in immunology research 김종훈 (연세대)
13:35-13:55 Multimodal and multiscale imaging of CAR T cells in a pancreatic adenocarcinoma xenograft model reveals negative effects of local IL-2 administration Rita Pfeifer (Miltenyi Biotec B.V. & Co. KG)
13:55-14:10 Break   
14:10-15:25 Immune Cell Analysis with bulk RNA Seq 최윤수 (서울대)
14:10-15:25 Introduction to bulk RNA-seq data analysis 김광수 (서울대)
15:25-15:40 Break   
15:40-16:55 [Industrial Session] Development of Novel Immunotherapeutics: Antibodies and Microbiome
*[건국의대 톨유사수용체 기반 질병 연구 센터]
박영민 (건국대)
박수형 (KAIST)
15:40-16:05 Mechanisms of Anticancer Activity of Bacteria in Enhancing Cancer Immunotherapy 박창욱 (이뮤노바이옴㈜)
16:05-16:30 ㈜ MD Healthcare 김윤근 (㈜ MD 헬스케어)
16:30-16:55 ㈜ ABL바이오- ABL503, a PD-L1 and 4-1BB Dual-Targeting Bispecific Antibody 정재호 (㈜ ABL바이오)
16:55-17:10 Break   
17:10-18:00 Special Symposium: Virus & Host Defense 송만기 (국제백신연구소)
17:10-17:40 T cell immune responses against SARS-CoV-2 신의철 (IBS)
17:40-18:10 age- and clade-dependent differential parthenogenesis of SARS-CoV-2 in animal models 최영기 (IBS)

시간 Session B 연자/좌장
Overview 이상일 (대한면역학회 총무위원장)
12:40-13:55 면역학연구 진흥을 위한 초청 강연 임종석 (숙명여대)
12:40-13:10 바이오분야 R&D 현황 및 추진계획(신약개발분야 R&D 현황) 김상현 단장 (연구재단)
13:10-13:40 How to collaborate with Korean R&D community 묵현상 단장 (국가신약개발사업단)
13:40-13:55 Discussion (Q&A)  
13:55-14:10 Break   
14:10-15:25 Animal Models of Immune Disorders 최제민 (한양대)
곽승기 (가톨릭대)
14:10-14:35 Mind the gap between animal model and human patients in COVID19 infection 성제경 (서울대)
14:35-15:00 Animal models of systemic autoimmune disease I 조미라 (가톨릭대)
15:00-15:25 Animal models of systemic autoimmune disease II 곽승기 (가톨릭대)
15:25-15:40 Break   
15:40-16:55 [Industrial Session] Development of Novel Immunotherapeutics: Antibodies and Microbiome
*[건국의대 톨유사수용체 기반 질병 연구 센터]
박영민 (건국대)
박수형 (KAIST)
15:40-16:05 Mechanisms of Anticancer Activity of Bacteria in Enhancing Cancer Immunotherapy 박창욱 (이뮤노바이옴㈜)
16:05-16:30 ㈜ MD Healthcare 김윤근 (㈜ MD 헬스케어)
16:30-16:55 ㈜ ABL바이오- ABL503, a PD-L1 and 4-1BB Dual-Targeting Bispecific Antibody 정재호 (㈜ ABL바이오)
16:55-17:10 Break   
17:10-18:00 Special Symposium: Virus & Host Defense 송만기 (국제백신연구소)
17:10-17:40 T cell immune responses against SARS-CoV-2 신의철 (IBS)
17:40-18:10 age- and clade-dependent differential parthenogenesis of SARS-CoV-2 in animal models 최영기 (IBS)